Navigation Links
Cytos Biotechnology Reports Results from Phase IIa Study with,CYT003-QbG10 in Patients Suffering from Atopic Dermatitis

SCHLIEREN (Zurich), Switzerland, July 3, 2007 - Cytos Biotechnology AG (SWX:CYTN) announced today results from a phase IIa study with CYT003-QbG10 in atopic dermatitis. CYT003-QbG10 is an immunotherapeutic product candidate currently in development for the treatment of allergic diseases. The present study aimed to assess safety, tolerability and exploratory efficacy of the product candidate in a new indication, namely atopic dermatitis. The study was designed as a placebo-controlled, randomized and double-blind trial in 36 patients suffering from mild to moderate atopic dermatitis (AD). Exploratory efficacy was determined according to the Eczema Area and Severity Index (EASI), a commonly applied test to assess the extent and severity of AD.

Treatment with CYT003-QbG10 was safe and generally well tolerated. In both the placebo-treated and CYT003-QbG10-treated groups a similar reduction of the EASI scores was measured over the study period indicating no treatment effect for CYT003-QbG10 in atopic dermatitis at the dose level tested in this trial.

Dr. Wolfgang Renner, CEO of Cytos Biotechnology, commented: “While CYT003-QbG10 has shown strong efficacy in conjunction with a specific allergen in patients with house dust mite allergy, we are still in the process of identifying the best treatment parameters for its application as a monotherapy. This monotherapy has achieved first promising results in grass pollen and also house dust mite allergy. For the latter indication we are now testing higher doses of the product candidate. Based on the outcome of these studies we will then also consider the path forward in atopic dermatitis.”

About the phase IIa study
The randomized, double-blind and placebo-controlled phase IIa study included 36 male and female patients aged 18 to 65 and suffering from mild to moderate AD. Upon entry into the study, the extent and severity of the disease was assessed by the Eczema Area Severit
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for the Treatment of Psoriasis
2. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
3. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
4. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
5. Prana Biotechnology Presents New Key Findings on PBT2
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
7. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
8. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
9. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
10. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
11. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
Post Your Comments:
(Date:3/27/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... trauma patients. Available in both small (6mm) ... External Fixation System from Zimmer is a modular system that ... The XtraFix System allows surgeons to eliminate steps, ... process, resulting in saved time, costs and overall team effort. ...
(Date:3/27/2015)... DALLAS , March 27, 2015 ... Market by Product (Diagnostic Catheter (Conventional, Advanced, Ultrasound), Ablation ... ICE, X-ray)) & Indication (AF, VT, WPW) - Global ... Market is expected to reach around ~$4.73 Billion by ... forecast period 2014 to 2019. Browse ...
(Date:3/27/2015)... BRUNSWICK, N.J. , March 27, 2015  Johnson & ... of Shareholders at 10 a.m. (Eastern Time) on Thursday, April ... Brunswick, N.J. Investors and other interested ... by visiting the Company,s website at www.jnj.com and ... presentations from the meeting will be made available a few ...
Breaking Medicine Technology:Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4
... Healthcare, a premier provider of support services to ... 3M to kick-off its powerfully enhanced approach to ... a hand-held 3M™ Clean-Trace™ NG Luminometer to measure ... material on the ATP swab—on small surface areas. ...
... SUNNYVALE, Calif., Dec. 28, 2010 Accuray Incorporated (Nasdaq: ... radiosurgery, announced today that its president and chief executive officer, ... 29th Annual J.P. Morgan Healthcare Conference in San Francisco on ... A live webcast of the presentation will be ...
Cached Medicine Technology:Crothall Healthcare Selects 3M™ Clean-Trace™ for Infection Control Verification 2Accuray Incorporated's CEO to Speak at 29th Annual J.P. Morgan Healthcare Conference 2
(Date:3/28/2015)... La Mirada, CA (PRWEB) March 28, 2015 ... with ear, nose and throat disorders, are ... Tinnitus is a common issue which is characterized by ... ears. Affecting 1 in 5 people, tinnitus is a ... or disorder and while it is non-fatal, tinnitus can ...
(Date:3/28/2015)... March 28, 2015 Designers and Professionals ... overlay entitled Scratches 5K from Pixel Film Studios. , ... to any media inside Final Cut Pro X” Said ... saves time and is an effective tool for any ... Overlay Scratches 5K's intuitive grunge overlays. Simply drag title ...
(Date:3/28/2015)... NY (PRWEB) March 28, 2015 ... of dietary supplements announces the release of their ... was shown in two randomized, double-blind, placebo-controlled clinical ... and waist and hip size. MuffinStop™ is a ... indicus and Garcinia mangostana, fused together to create ...
(Date:3/28/2015)... 28, 2015 LTW Cyber is an ... collaborate for the purpose of addressing the needs of ... pursue its own opportunities to grow while seeking collaborative ... LTW Cyber. , Ventures in LTW Cyber focus on ... by offerings identifying vulnerabilities and analyzing open source. ...
(Date:3/27/2015)... Wellness for Cancer–the first organization to ... the spa and wellness industry–has certified Hands On to ... or are living with cancer. Hands On , ... will be identified with a special Wellness for Cancer ... safe, therapeutic services for cancer patients. , Wellness for ...
Breaking Medicine News(10 mins):Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4
... By Maureen Salamon HealthDay Reporter , TUESDAY, ... the body to attack tumor cells has shown promise ... cancer patients, improving overall survival times and stopping the ... The PANVAC vaccine, administered to 26 women through monthly ...
... , RICHMOND, Va. (Nov. 8, 2011) A team of ... of 19-month-old conjoined twins Maria and Teresa Tapia of the ... around 6 a.m. and was the first surgery of its ... by David Lanning, M.D., Ph.D., associate professor in the VCU ...
... (HealthDay News) -- The reversal of a kidney allocation policy ... from a deceased donor, U.S. researchers say. Until 2003, ... potential recipients who had a genetic match with the deceased ... body,s immune response to foreign tissue. HLA-B similarity tends to ...
... their opioid abuse when given sustained treatment with the ... in yesterday,s Archives of General Psychiatry and ... part of the National Institutes of Health. The study, ... using a medication for the treatment of prescription opioid ...
... proper bone health, a number of research studies have linked it ... unique among vitamins in that it is made by the body ... foods. Recent studies have confirmed that vitamin D deficiency is common, ... HIV-positive, of all ages and all races, may be at particularly ...
... Almac scientists, research have been published in the online version ... ) ahead of the print edition of the journal. The ... Clinical Oncology (ASCO), the world,s leading professional society representing physicians ... the third most common cancer in the US. Over 100,000 ...
Cached Medicine News:Health News:Vaccine to Treat Breast, Ovarian Cancers Shows Promise 2Health News:Vaccine to Treat Breast, Ovarian Cancers Shows Promise 3Health News:VCU performs separation surgery on conjoined twins 2Health News:VCU performs separation surgery on conjoined twins 3Health News:Racial Disparities Still Exist for Kidney Recipients, Study Finds 2Health News:Painkiller abuse treated by sustained buprenorphine/naloxone 2Health News:Painkiller abuse treated by sustained buprenorphine/naloxone 3Health News:UH Rainbow Babies & Children's Hospital begins studies on vitamin D to prevent heart disease 2Health News:Northern Ireland company makes major breakthrough in cancer treatment 2
... A unique sliding microtome with automatic ... return travel. Maintenance-free precision cross roller ... and specialty applications in biological, botany, ... to 155 x 90 mm can ...
... Leica Microsystems offers a fully ... CV5030 is designed to coverslip microscope ... cytopathology smears. The instrument accepts quality-grade ... all common mounting media. The capability ...
... The ideal system for specimen surface ... with the ultramilling attachment Leica SP2600. ,Ultramilling ... microtomy and saw microtomy in sample preparation. ... soft materials are located side by side ...
... IOL with OptiEdge offers design innovations that ... and excellent handling. The biostable acrylic material ... of vacuoles; the patented OptiEdge is designed ... 360 degrees of contact with the posterior ...
Medicine Products: